Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
Intravenous Lidocaine for the Management of Chronic Pain: A Narrative Review of Randomized Clinical Trials
1
x
$
30.00
Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder
1
x
$
30.00
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
1
x
$
30.00
Ahmad Ghanizadeh - Can Fluoxetine Alone Cause Serotonin Syndrome in Adolescents?
1
x
$
30.00
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
1
x
$
30.00
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
1
x
$
0.00
J. Douglas Bremner, MD: Does Isotretinoin Cause Depression and Suicide?
1
x
$
30.00
Alexander Neumeister, MD: Tryptophan Depletion, Serotonin, and Depression: Where Do We Stand?
1
x
$
30.00
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
1
x
$
30.00
C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update
1
x
$
30.00
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
1
x
$
30.00
Lasmiditan for the Treatment of Migraines With or Without Aura in Adults (OPEN ACCESS)
1
x
$
0.00
View Cart
Checkout
Home
Store
“Lasmiditan for the Treatment of Migraines With or Without Aura in Adults (OPEN ACCESS)” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Estudios poblacionales de la relación entre el traumatismo craneoencefálico y la psiquiatría
$
0.00
Add to cart
Details
Michael E. Thase, MD: Editor’s Letter
$
0.00
Add to cart
Details
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
$
30.00
Add to cart
Details
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY: AUTHOR REPLY
$
0.00
Add to cart
Details
LETTER TO THE EDITOR: GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY
$
0.00
Add to cart
Details
Hypomania Induced by Escitalopram: 2 Case Reports
$
30.00
Add to cart
Details
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
$
30.00
Add to cart
Details
Antidepressant Induced Apathy Responsive to Dose Reduction
$
30.00
Add to cart
Details
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Double-Blind, Placebo-Controlled Pilot Study
$
30.00
Add to cart
Details
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
$
30.00
Add to cart
Details
Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
$
30.00
Add to cart
Details
Predictive Value of Early Improvement in Bipolar Depression Trials: A Post-hoc Pooled Analysis of Two 8-week Aripiprazole Studies
$
30.00
Add to cart
Details
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
$
30.00
Add to cart
Details
Effectiveness of a Brain-Computer Interface Based Programme for the Treatment of ADHD: A Pilot Study
$
30.00
Add to cart
Details
The Effects of Psychotropic Medications on Human Sexuality
$
30.00
Add to cart
Details
Clinton D. Kilts, PhD: Imaging the Roles of the Amygdala in Drug Addiction
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$
30.00
Add to cart
Details
Gary M. Levin, PharmD: A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir
$
30.00
Add to cart
Details
Mark S. Bauer, MD: An Evidence-Based Review of Psychosocial Treatments for Bipolar Disorder
$
30.00
Add to cart
Details
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
$
30.00
Add to cart
Details
Previous
1
…
20
21
22
…
44
Next
Page load link
Go to Top
